VRAX icon

Virax Biolabs
VRAX

6 hedge funds and large institutions have $12.1K invested in Virax Biolabs in 2025 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

79% less capital invested

Capital invested by funds: $57.1K → $12.1K (-$45K)

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$10.9K
2
+$2.1K
3
+$10
4
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
+$5

Top Sellers

1
-$36K
2
-$13K
3
-$2.04K
Name Holding Trade Value Shares
Change 		Change in
Stake
XT
1
XTX Topco
Cayman Islands
$7.41K
UBS Group
2
UBS Group
Switzerland
$2.59K
National Bank of Canada
3
National Bank of Canada
Quebec, Canada
$2.07K
FFA
4
Farther Finance Advisors
California
$7
Osaic Holdings
5
Osaic Holdings
Arizona
$7
Northwestern Mutual Wealth Management
6
Northwestern Mutual Wealth Management
Wisconsin
$3
HF
7
HRT Financial
New York
–
VF
8
Virtu Financial
New York
–